ORFORD MINING CORP (ORM.CA) Fundamental Analysis & Valuation

TSX-V:ORMCA68617N1015

Current stock price

0.105 CAD
0 (0%)
Last:

This ORM.CA fundamental analysis includes valuation metrics, fair value assessment, financial health analysis, profitability trends, growth metrics and dividend sustainability analysis.

1

1. ORM.CA Profitability Analysis

1.1 Basic Checks

  • In the past year ORM has reported negative net income.
  • ORM had a negative operating cash flow in the past year.
ORM.CA Yearly Net Income VS EBIT VS OCF VS FCFORM.CA Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2016 2017 2018 2019 2020 2021 2022 -2M -4M -6M

1.2 Ratios

  • With a Return On Assets value of -11.82%, ORM perfoms like the industry average, outperforming 55.34% of the companies in the same industry.
  • The Return On Equity of ORM (-16.32%) is comparable to the rest of the industry.
Industry RankSector Rank
ROA -11.82%
ROE -16.32%
ROIC N/A
ROA(3y)-8.48%
ROA(5y)-18.68%
ROE(3y)-11.63%
ROE(5y)-26%
ROIC(3y)N/A
ROIC(5y)N/A
ORM.CA Yearly ROA, ROE, ROICORM.CA Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2016 2017 2018 2019 2020 2021 2022 -20 -40 -60 -80 -100

1.3 Margins

  • The Profit Margin and Operating Margin and Gross Margin are not available for ORM so they could not be analyzed.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM N/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
ORM.CA Yearly Profit, Operating, Gross MarginsORM.CA Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2016 2017 2018 2019 2020 2021 2022

5

2. ORM.CA Health Analysis

2.1 Basic Checks

  • The number of shares outstanding for ORM has been increased compared to 1 year ago.
  • There is no outstanding debt for ORM. This means it has a Debt/Equity and Debt/FCF ratio of 0 and it is amongst the best of the sector and industry.
ORM.CA Yearly Shares OutstandingORM.CA Yearly Shares OutstandingYearly Shares Outstanding 2016 2017 2018 2019 2020 2021 2022 50M 100M 150M
ORM.CA Yearly Total Debt VS Total AssetsORM.CA Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2016 2017 2018 2019 2020 2021 2022 5M 10M 15M

2.2 Solvency

  • Based on the Altman-Z score of -0.11, we must say that ORM is in the distress zone and has some risk of bankruptcy.
  • ORM's Altman-Z score of -0.11 is in line compared to the rest of the industry. ORM outperforms 40.61% of its industry peers.
  • There is no outstanding debt for ORM. This means it has a Debt/Equity and Debt/FCF ratio of 0 and it is amongst the best of the sector and industry.
Industry RankSector Rank
Debt/Equity 0
Debt/FCF N/A
Altman-Z -0.11
ROIC/WACCN/A
WACCN/A
ORM.CA Yearly LT Debt VS Equity VS FCFORM.CA Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2016 2017 2018 2019 2020 2021 2022 0 5M -5M 10M

2.3 Liquidity

  • A Current Ratio of 1.27 indicates that ORM should not have too much problems paying its short term obligations.
  • With a Current ratio value of 1.27, ORM is not doing good in the industry: 62.58% of the companies in the same industry are doing better.
  • ORM has a Quick Ratio of 1.27. This is a normal value and indicates that ORM is financially healthy and should not expect problems in meeting its short term obligations.
  • ORM has a Quick ratio (1.27) which is comparable to the rest of the industry.
Industry RankSector Rank
Current Ratio 1.27
Quick Ratio 1.27
ORM.CA Yearly Current Assets VS Current LiabilitesORM.CA Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2016 2017 2018 2019 2020 2021 2022 2M 4M 6M

0

3. ORM.CA Growth Analysis

3.1 Past

  • The earnings per share for ORM have decreased strongly by -10.46% in the last year.
EPS 1Y (TTM)-10.46%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-203.46%
Revenue 1Y (TTM)N/A
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%N/A

3.2 Future

  • No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
  • No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

  • No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
  • No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.

0

4. ORM.CA Valuation Analysis

4.1 Price/Earnings Ratio

  • The Price/Earnings Ratio is negative for ORM. In the last year negative earnings were reported.
Industry RankSector Rank
PE N/A
Fwd PE N/A
ORM.CA Price Earnings VS Forward Price EarningsORM.CA Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 0 0 0 0 0 0 0 0 0 0

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A
ORM.CA Per share dataORM.CA EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 0.02 -0.02 0.04 0.06

4.3 Compensation for Growth

PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2YN/A
EPS Next 3YN/A

0

5. ORM.CA Dividend Analysis

5.1 Amount

  • No dividends for ORM!.
Industry RankSector Rank
Dividend Yield N/A

ORM.CA Fundamentals: All Metrics, Ratios and Statistics

ORFORD MINING CORP

TSX-V:ORM (4/2/2024, 7:00:00 PM)

0.105

0 (0%)

Chartmill FA Rating
GICS SectorMaterials
GICS IndustryGroupMaterials
GICS IndustryMetals & Mining
Earnings (Last)N/A
Earnings (Next)N/A
Inst Owners3.23%
Inst Owner ChangeN/A
Ins OwnersN/A
Ins Owner ChangeN/A
Market Cap23.29M
Revenue(TTM)N/A
Net Income(TTM)-2.84M
Analysts0
Price TargetN/A
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)N/A
PT rev (3m)N/A
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)N/A
EPS NY rev (3m)N/A
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)N/A
Revenue NY rev (3m)N/A
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S N/A
P/FCF N/A
P/OCF N/A
P/B 1.34
P/tB 1.34
EV/EBITDA N/A
EPS(TTM)-0.02
EYN/A
EPS(NY)N/A
Fwd EYN/A
FCF(TTM)-0.03
FCFYN/A
OCF(TTM)-0.01
OCFYN/A
SpS0
BVpS0.08
TBVpS0.08
PEG (NY)N/A
PEG (5Y)N/A
Graham NumberN/A
Profitability
Industry RankSector Rank
ROA -11.82%
ROE -16.32%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM N/A
FCFM N/A
ROA(3y)-8.48%
ROA(5y)-18.68%
ROE(3y)-11.63%
ROE(5y)-26%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexgc growth 3YN/A
ROICexgc growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
F-Score4
Asset Turnover0
Health
Industry RankSector Rank
Debt/Equity 0
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr N/A
Cap/Sales N/A
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 1.27
Quick Ratio 1.27
Altman-Z -0.11
F-Score4
WACCN/A
ROIC/WACCN/A
Cap/Depr(3y)N/A
Cap/Depr(5y)N/A
Cap/Sales(3y)N/A
Cap/Sales(5y)N/A
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-10.46%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-203.46%
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)N/A
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%N/A
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y-64.26%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next YearN/A
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y-27.67%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y-44.25%
OCF growth 3YN/A
OCF growth 5YN/A

ORFORD MINING CORP / ORM.CA Fundamental Analysis FAQ

What is the fundamental rating for ORM stock?

ChartMill assigns a fundamental rating of 2 / 10 to ORM.CA.


What is the valuation status for ORM stock?

ChartMill assigns a valuation rating of 0 / 10 to ORFORD MINING CORP (ORM.CA). This can be considered as Overvalued.


Can you provide the profitability details for ORFORD MINING CORP?

ORFORD MINING CORP (ORM.CA) has a profitability rating of 1 / 10.